Welcome to our dedicated page for Advanced Flower Capital SEC filings (Ticker: AFCG), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Advanced Flower Capital Inc. filings document the regulatory record of a Nasdaq-listed business development company that makes direct senior debt investments for lower middle-market borrowers. Its 8-K reports furnish operating results, financial presentations, net investment income, NAV, Distributable Earnings, distributions, investment fundings, and leverage disclosures.
The company’s filings also cover material definitive agreements and direct financial obligations, including revolving credit agreements and amendments to its loan and security agreement. Proxy and shareholder-vote materials document governance matters, director elections, auditor ratification, the investment advisory agreement with AFC Management, LLC, reduced asset coverage matters under the Investment Company Act of 1940, and capital-structure information for AFCG common stock.
Advanced Flower Capital Inc. reported an insider purchase by a director and 10% owner. On 12/11/2025, the reporting person bought 25,000 shares of common stock at a weighted average price of $3.05 per share in open-market transactions.
After the trade, the reporting person beneficially owned 5,861,098 shares directly, 218,907 shares held by a spouse, and 180,400 shares held by the Tannenbaum Family Foundation, where the reporting person serves as President and disclaims beneficial ownership except for any pecuniary interest. The reported price reflects multiple trades executed between $3.03 and $3.10.
Advanced Flower Capital Inc. (AFCG) reported a Form 4 showing that a director acquired common stock through an equity grant. On November 20, 2025, the director received 5,474 shares of AFCG common stock at a price of $2.74 per share. Following this transaction, the director beneficially owned 24,539 shares on a direct basis.
The filing explains that the award represents restricted stock granted under the company’s Stock Incentive Plan, and that this restricted stock was fully vested as of November 20, 2025. The form was filed for one reporting person and signed by an attorney-in-fact on the reporting person’s behalf.
Advanced Flower Capital Inc. (AFCG) reported an insider equity award for one of its directors. On November 20, 2025, the director acquired 5,474 shares of common stock as an award of restricted stock under the company’s Stock Incentive Plan. The filing notes that this restricted stock is fully vested as of November 20, 2025, meaning the director’s ownership rights are not subject to further service-based vesting conditions.
After this transaction, the director beneficially owns 9,511 shares of AFCG common stock, held directly. The transaction price reported for the award is $2.74 per share. This is a routine Form 4 disclosure showing equity-based compensation to a board member, which marginally increases insider ownership.
Advanced Flower Capital Inc. (AFCG) reported an insider equity grant to a director. On November 20, 2025, the director acquired 5,474 shares of common stock as restricted stock under the company’s Stock Incentive Plan. The filing notes this restricted stock is fully vested as of that date and was recorded at a price of $2.74 per share.
Following this grant, the director beneficially owns 9,511 shares of AFCG common stock held directly. This is a routine equity-based compensation event that modestly increases the director’s ownership stake and further aligns their interests with other shareholders.
Advanced Flower Capital Inc. (AFCG) director reported acquiring additional common stock through an equity grant. On November 20, 2025, the director received 5,474 shares of fully vested restricted stock under the company’s stock incentive plan at a price of $2.74 per share. Following this grant, the director beneficially owns 16,196 shares of AFCG common stock held directly.
Advanced Flower Capital Inc. (AFCG) reported an insider equity award for its Chief Executive Officer. On 11/20/2025, the CEO acquired 91,240 shares of common stock as restricted stock granted under the company’s Stock Incentive Plan, fully vested as of that date, at a price of $2.74 per share. Following this grant, the CEO beneficially owns 317,889 shares of AFCG common stock in direct ownership. This filing is a disclosure of executive equity compensation and does not reflect an open-market purchase or sale.
Advanced Flower Capital Inc. (AFCG) reported an insider equity award for its President and CIO on a Form 4. On November 20, 2025, the executive acquired 91,240 shares of common stock as fully vested restricted stock granted under the company’s stock incentive plan at a price of $2.74 per share.
Following this transaction, the executive directly held 218,907 shares of AFCG common stock. Additional shares are reported as indirectly owned through the executive’s spouse and the Tannenbaum Family Foundation, but the executive disclaims beneficial ownership of those securities except to the extent of any pecuniary interest.
Advanced Flower Capital Inc. (AFCG) director and 10% owner reported acquiring 729,927 shares of common stock on November 20, 2025 as a fully vested restricted stock grant under the company’s stock incentive plan, at a reported price of $2.74 per share. Following this transaction, the reporting person directly owns 5,692,098 shares of AFCG common stock.
In addition to these directly held shares, the filing shows indirect holdings of 218,907 shares held by the reporting person’s spouse and 180,400 shares held by the Tannenbaum Family Foundation, where the reporting person serves as President. The reporting person disclaims beneficial ownership of the spouse and foundation shares except to the extent of any pecuniary interest.
Advanced Flower Capital Inc. (AFCG) Chief Executive Officer reported an open‑market purchase of company stock. On 11/18/2025, the reporting person bought 17,000 shares of common stock in a single reportable transaction coded "P" for purchase. The weighted average price was $2.81 per share, with individual trades executed between $2.79 and $2.81.
Following this transaction, the reporting person beneficially owned 226,649 shares of AFCG common stock, held directly. The filer has undertaken to provide full trade details, including the number of shares and exact prices for each execution, to the SEC staff, the issuer, or any security holder upon request.
Advanced Flower Capital Inc. furnished an update on operations and financial condition by announcing it issued a press release for the quarter ended September 30, 2025. The press release is included as Exhibit 99.1. The information under Item 2.02, including the exhibit, is being furnished and is not deemed filed or incorporated by reference except as expressly set forth.